Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 31.25
0.00 (0.00%)
Aug 19, 2026, 1:22 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.12 billion as of August 18, 2026. Its market cap has increased by 7.57% in one year.
Market Cap
3.12B
Enterprise Value
2.42B
Revenue
1.87B
Ranking
n/a
PE Ratio
16.53
Stock Price
31.25
ChartMarket Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.12B, an increase of 119.19%. That is a compound annual growth rate of 3.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 3.12B | 2.63% |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.46B |
| Senhwa Biosciences | 3.44B |
| OBI Pharma | 3.41B |
| BioGend Therapeutics | 3.40B |
| SYN-TECH Chem. & Pharm. | 3.32B |
| Sagittarius Life Science | 3.30B |
| Shine-On BioMedical | 3.16B |
| 3D Global Biotech | 3.09B |